Harvest Fund Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$499K Buy
7,724
+2,830
+58% +$200K 0.02% 208
2025
Q4
$329K Hold
4,894
0.01% 310
2025
Q3
$359K Buy
4,894
+4,889
+97,780% +$325K 0.02% 292
2025
Q2
$0 Sell
5
-1,387
-100% -$78.9K ﹤0.01% 680
2025
Q1
$89K Buy
+1,392
New +$80.9K ﹤0.01% 451
2024
Q4
Sell
-2,849
Closed -$163K 775
2024
Q3
$163K Buy
+2,849
New +$163K 0.01% 365
2023
Q1
Sell
-1,002
Closed -$57K 777
2022
Q4
$57K Buy
+1,002
New +$51.3K 0.01% 447
2022
Q3
Sell
-1,973
Closed -$87K 814
2022
Q2
$87K Buy
+1,973
New +$85.3K 0.02% 331
2021
Q4
Sell
-473
Closed -$19K 787
2021
Q3
$19K Sell
473
-366
-44% -$15.3K ﹤0.01% 595
2021
Q2
$38K Sell
839
-838
-50% -$37.1K ﹤0.01% 494
2021
Q1
$69K Hold
1,677
0.01% 329
2020
Q4
$71K Hold
1,677
0.01% 316
2020
Q3
$44K Buy
+1,677
New +$46.7K ﹤0.01% 408

Other funds holding HALO

Harvest Fund Management's HALO Position: Q1 2026 in Review

Harvest Fund Management increased its Halozyme (HALO) stake by 58% in Q1 2026, buying an estimated $200K and bringing the position to 7,724 shares worth $499K. The position accounts for 0.02% of the portfolio, ranked #208.

Harvest Fund Management first reported a position in HALO in Q3 2020 and has held it in 13 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Harvest Fund Management held 7,724 shares of Halozyme worth $499K as of Q1 2026.
  • Harvest Fund Management bought 2,830 Halozyme shares in Q1 2026, an estimated $200K.
  • Halozyme made up 0.02% of Harvest Fund Management's portfolio in Q1 2026, its #208 holding.
  • Harvest Fund Management first reported a position in Halozyme in Q3 2020 and has held it in 13 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.